# Avery Dennison Corp: Form 10-Q for the period ended Sep 30, 2017

- Company: [Avery Dennison Corp](/companies/avy.md) (CIK 8818)
- Form: 10-Q
- Filed: 2017-10-31
- Accepted by EDGAR: Oct 31, 2017, 15:03 ET
- Period: 2017-09-30
- Accession: 0001104659-17-064943
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/8818/000110465917064943/a17-20567_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/8818/000110465917064943/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Gross profit | 3 months, 2017-07-02 to 2017-09-30 | $451.6m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2017-01-01 to 2017-09-30 | $1.35bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2017-07-02 to 2017-09-30 | $277.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2017-01-01 to 2017-09-30 | $837.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2017-07-02 to 2017-09-30 | $16.8m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2017-01-01 to 2017-09-30 | $49.7m | us-gaap:InterestExpense |
| Income tax | 3 months, 2017-07-02 to 2017-09-30 | $38.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2017-01-01 to 2017-09-30 | $90.8m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months, 2017-07-02 to 2017-09-30 | $1.20 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2017-01-01 to 2017-09-30 | $3.79 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-07-02 to 2017-09-30 | $1.23 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2017-01-01 to 2017-09-30 | $3.86 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-07-02 to 2017-09-30 | 89,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2017-01-01 to 2017-09-30 | 90,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2017-01-01 to 2017-09-30 | $392.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2017-01-01 to 2017-09-30 | $111.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2017-01-01 to 2017-09-30 | $115.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2017-01-01 to 2017-09-30 | $104.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-09-30 | $232.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-09-30 | $2.28bn | us-gaap:AssetsCurrent |
| Total assets | at 2017-09-30 | $5.27bn | us-gaap:Assets |
| Current liabilities | at 2017-09-30 | $2.02bn | us-gaap:LiabilitiesCurrent |
| Current portion of debt | at 2017-09-30 | $383.0m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2017-09-30 | $1.13bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 45,380 characters.

Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, provides management’s views on our financial condition and results of operations, should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements and notes thereto, and includes the following sections:

|  |  |
| --- | ---: |
| Non-GAAP Financial Measures | 19 |
| Overview and Outlook | 20 |
| Analysis of Results of Operations for the Third Quarter | 21 |
| Results of Operations by Reportable Segment for the Third Quarter | 22 |
| Analysis of Results of Operations for the Nine Months Year-to-Date | 24 |
| Results of Operations by Reportable Segment for the Nine Months Year-to-Date | 26 |
| Financial Condition | 28 |
| Recent Accounting Requirements | 32 |

### NON-GAAP FINANCIAL MEASURES

We report our financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement the presentation of our financial results that are prepared in accordance with GAAP. Based upon feedback from investors and financial analysts, we believe that the supplemental non-GAAP financial measures we provide are useful to their assessments of our performance and operating trends, as well as liquidity.

Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it difficult to assess our underlying performance in a single period. By excluding the accounting effects, positive or negative, of certain items (e.g., restructuring charges, legal settlements, certain effects of strategic transactions and related costs, losses from debt extinguishments, gains and losses from curtailment and settlement of pension obligations, gains or losses on sales of certain assets, and other items), we believe that we are providing meaningful supplemental information to facilitate an understanding of our core operating results and liquidity measures. These non-GAAP financial measures are used internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for a single period. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing.

We use the following non-GAAP financial measures in this MD&A:

- *Sales change ex. currency* refers to the increase or decrease in sales excluding the estimated impact of foreign currency translation. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of foreign currency fluctuations.
- *Organic sales change* refers to the increase or decrease in sales excluding the estimated impact of foreign currency translation, product line exits, acquisitions and divestitures, and, where applicable, an extra week in our fiscal year.

We believe that sales change ex. currency and organic sales change assist investors in evaluating the sales growth from our businesses and better enable them to evaluate our results from period to period.

- *Free cash flow* refers to cash flow from operations, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from sales (purchases) of investments. We believe that free cash flow assists investors by indicating the amount of cash we have available for debt reductions, dividends, share repurchases, and acquisitions.
- *Operational working capital* refers to trade accounts receivable and inventories, net of accounts payable, and excludes cash and cash equivalents, short-term borrowings, deferred taxes, other current assets and other current liabilities, as well as net current assets or liabilities held-for-sale. We believe that operational working capital assists investors in assessing our working capital requirements because it excludes the impact of fluctuations attributable to our financing and other activities (which affect cash and cash equivalents, deferred taxes, other current assets, and other current liabilities) that tend to be disparate in amount, frequency, or timing, and that may increase the volatility of working capital as a percentage of sales from period to period. The items excluded from this measure are not significantly influenced by our day-to-day activities managed at the operating level and do not necessarily reflect the underlying trends in our operations.

### OVERVIEW AND OUTLOOK

### Net Sales

The factors impacting reported sales change are shown in the table below:

|  | Three Months Ended September 30, 2017 | Nine Months Ended September 30, 2017 |
| --- | ---: | ---: |
| Reported sales change | 11% | 8% |
| Foreign currency translation | (1) | – |
| Sales change ex. currency | 10% | 8% |
| Acquisitions/divestitures | (5) | (4) |
| Organic sales change | 5% | 4% |

In the three and nine months ended September 30, 2017, net sales increased on an organic basis due to higher volume.

### Net Income

Net income increased approximately $83 million in the first nine months of 2017 compared to the same period last year. Major factors affecting net income in the first nine months of 2017 included:

Positive factors:

- Volume/mix
- Benefits from productivity initiatives, including savings from restructuring actions, net of transition costs
- Prior year loss from settlement of pension obligations

Offsetting factors:

- Higher employee-related costs
- The net impact of pricing and raw material costs
- Higher restructuring charges

### Acquisitions

During the first nine months of 2017, we completed the 2017 Acquisitions, which were not material, individually or in the aggregate, to our unaudited Condensed Consolidated Financial Statements. Refer to Note 2, “Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Cost Reduction Actions

#### 2015/2016 Actions

During the nine months ended September 30, 2017, we recorded $24.4 million in restructuring charges, net of reversals, related to the 2015/2016 Actions. These charges consisted of severance and related costs for the reduction of approximately 670 positions, lease cancellation costs, and asset impairment charges.

#### Impact of Cost Reduction Actions

We anticipate incremental savings, net of transition costs, from the 2015/2016 Actions to be approximately $50 million to $55 million in 2017. We estimate cash restructuring costs to be approximately $35 million in 2017.

Restructuring charges were included in “Other expense, net” in the unaudited Condensed Consolidated Statements of Income. Refer to Note 9, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Free Cash Flow

*(In millions)*

|  | Nine Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $392.6 | $365.7 |
| Purchases of property, plant and equipment | (111.4) | (104.9) |
| Purchases of software and other deferred charges | (23.5) | (16.6) |
| Proceeds from sales of property, plant and equipment | 3.0 | 4.3 |
| Purchases of investments, net | (4.7) | (.8) |
| Free cash flow | $256.0 | $247.7 |

20

Free cash flow in the first nine months of 2017 increased compared to the same period last year primarily due to higher net income, partially offset by higher net capital and software expenditures and purchases of investments, higher income tax payments, net of refunds, and operational working capital improvements in the prior year, the benefit of which did not repeat in the current year. Free cash flow in the first nine months of 2017 also reflected the impact of our adoption of the accounting guidance update related to stock-based payments described in Note 1, “General,” to the unaudited Condensed Consolidated Financial Statements.

### Outlook

Certain factors that we believe may contribute to results for 2017 are described below:

- We expect our net sales to increase by approximately 8%.
- We expect our full year effective tax rate to be approximately 28%.
- We anticipate our capital and software expenditures to be approximately $215 million.
- We estimate pre-tax cash restructuring and certain acquisition-related transaction costs to total approximately $40 million.

### ANALYSIS OF RESULTS OF OPERATIONS FOR THE THIRD QUARTER

### Income before Taxes

*(Dollars in millions)*

|  | Three Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Net sales | $1,679.5 | $1,508.7 |
| Cost of products sold | 1,227.9 | 1,091.1 |
| Gross profit | 451.6 | 417.6 |
| Marketing, general and administrative expense | 277.2 | 270.3 |
| Interest expense | 16.8 | 14.7 |
| Other expense, net | 10.8 | 4.6 |
| Income before taxes | $146.8 | $128.0 |
| Gross profit margin | 26.9% | 27.7% |

#### Gross Profit Margin

Gross profit margin for the third quarter of 2017 decreased compared to the same period last year primarily driven by acquisitions as well as the net impact of pricing and raw material costs in our Label and Graphic Materials and Industrial and Healthcare Materials reportable segments.

#### Marketing, General and Administrative Expense

Marketing, general and administrative expense increased in the third quarter of 2017 compared to the same period last year reflecting higher employee-related costs and the impact of acquisitions, partially offset by benefits from productivity initiatives, including savings from restructuring, net of transition costs.

#### Other Expense, net

*(In millions)*

| Other expense, net by type Restructuring charges: | Three Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Severance and related costs | $8.7 | $1.9 |
| Asset impairment charges and lease cancellation costs | 1.8 | .7 |
| Other items: |  |  |
| Transaction costs | .3 | 2.0 |
| Other expense, net | $10.8 | $4.6 |

Refer to Note 9, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding charges associated with restructuring.

### Net Income and Earnings per Share

*(Dollars in millions, except per share amounts)*

|  | Three Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Income before taxes | $146.8 | $128.0 |
| Provision for income taxes | 38.5 | 38.9 |
| Net income | $108.3 | $89.1 |
| Net income per common share | $1.23 | $1.00 |
| Net income per common share, assuming dilution | 1.20 | .98 |
| Effective tax rate | 26.2% | 30.4% |

#### Provision for Income Taxes

The effective tax rate for the three months ended September 30, 2017 included $1.7 million of tax benefit from the releases of valuation allowances on certain U.S. state deferred tax assets and $1.1 million of tax benefit from the effective settlements of certain tax examinations and changes in our judgment about tax filing positions as a result of new information.

The effective tax rate for the three months ended September 30, 2017 also included the immediate recognition of $1.6 million of tax expense primarily from intra-entity sales and transfers of assets other than inventory related to the integration of a recent acquisition. The remaining tax effects were recognized as deferred tax charges and recorded in “Other current assets” and “Other assets.” However, we expect the deferred tax charges to be derecognized as an adjustment to retained earnings upon adoption of the accounting guidance update described in Note 17, “Recent Accounting Requirements,” to the unaudited Condensed Consolidated Financial Statements.

In addition, the effective tax rate for the three months ended September 30, 2017 compared to the same period last year reflects a decrease in tax expense related to the repatriation of non-permanently reinvested earnings of certain foreign subsidiaries and favorable changes in the geographic mix of our income before taxes.

The effective tax rate for the three months ended October 1, 2016 included $4.8 million of tax expense resulting from return to provision adjustments pursuant to the completion of the 2015 U.S. federal tax return; $1 million of tax benefit from our change in judgment about tax filing positions in certain foreign jurisdictions as a result of new information gained from our interactions with tax authorities; $17.7 million of tax expense associated with the tax cost to repatriate non-permanently reinvested earnings of certain foreign subsidiaries; and $11.1 million of tax benefit resulting from effective settlements of tax examinations in various foreign jurisdictions.

Our effective tax rate can vary widely from quarter to quarter due to interim reporting requirements, the recognition of discrete events, and the timing of repatriation of foreign earnings. Refer to Note 11, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for further information.

### RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE THIRD QUARTER

Operating income refers to income before interest and taxes.

### Label and Graphic Materials

*(In millions)*

|  | Three Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $1,153.5 | $1,062.9 |
| Less intersegment sales | (16.2) | (16.6) |
| Net sales | $1,137.3 | $1,046.3 |
| Operating income(1) | 145.5 | 130.7 |
| (1) Included costs associated with restructuring and transaction costs in both quarters. | $3.2 | $2.7 |

22

#### Net Sales

The factors impacting reported sales change are shown in the table below:

|  | Three Months Ended September 30, 2017 |
| --- | ---: |
| Reported sales change | 9% |
| Foreign currency translation | (2) |
| Sales change ex. currency | 7% |
| Acquisitions | (2) |
| Organic sales change | 5% |

In the third quarter of 2017, net sales increased on an organic basis due to higher volume. Sales increased on an organic basis at a high-single digit rate in emerging markets, a mid-single digit rate in Western Europe, and a low-single digit rate in North America.

#### Operating Income

Operating income increased in the third quarter of 2017 compared to the same period last year due to higher volume and benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, partially offset by higher employee-related costs and the net impact of pricing and raw material costs.

### Retail Branding and Information Solutions

*(In millions)*

|  | Three Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $374.5 | $352.1 |
| Less intersegment sales | (.7) | (.6) |
| Net sales | $373.8 | $351.5 |
| Operating income(1) | 25.3 | 23.2 |
| (1)Included costs associated with restructuring in both quarters. | $7.4 | $1.5 |

#### Net Sales

The factors impacting reported sales change are shown in the table below:

|  | Three Months Ended September 30, 2017 |
| --- | ---: |
| Reported sales change | 6% |
| Foreign currency translation | – |
| Sales change ex. currency(1) | 7% |
| Organic sales change | 7% |

(1) Total may not sum due to rounding

In the third quarter of 2017, net sales increased on an organic basis due to higher volume, reflecting growth of both radio-frequency identification products and base apparel tickets and tags.

#### Operating Income

Operating income increased in the third quarter of 2017 due to higher volume, benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, and lower amortization expense, partially offset by higher employee-related costs and higher restructuring charges.

### Industrial and Healthcare Materials

*(In millions)*

|  | Three Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $170.5 | $112.5 |
| Less intersegment sales | (2.1) | (1.6) |
| Net sales | $168.4 | $110.9 |
| Operating income(1) | 13.8 | 12.3 |
| (1)Included transaction costs in 2017 and costs associated with restructuring in 2016. | $.2 | $.4 |

#### Net Sales

The factors impacting reported sales change are shown in the table below:

|  | Three Months Ended September 30, 2017 |
| --- | ---: |
| Reported sales change | 52% |
| Foreign currency translation | (2) |
| Sales change ex. currency | 50% |
| Acquisitions | (47) |
| Organic sales change | 3% |

In the third quarter of 2017, net sales increased on an organic basis due to volume growth in both industrial and healthcare categories.

#### Operating Income

Operating income increased in the third quarter of 2017 compared to the same period last year due to higher volume and benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, partially offset by acquisition-related costs, higher employee-related costs, and the net impact of pricing and raw material costs.

### ANALYSIS OF RESULTS OF OPERATIONS FOR THE NINE MONTHS YEAR-TO-DATE

### Income before Taxes

*(Dollars in millions)*

|  | Nine Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Net sales | $4,878.5 | $4,535.7 |
| Cost of products sold | 3,531.9 | 3,261.4 |
| Gross profit | 1,346.6 | 1,274.3 |
| Marketing, general and administrative expense | 837.2 | 817.7 |
| Interest expense | 49.7 | 45.4 |
| Other expense, net | 27.5 | 60.4 |
| Income from continuing operations before taxes | $432.2 | $350.8 |
| Gross profit margin | 27.6% | 28.1% |

#### Gross Profit Margin

Gross profit margin for the first nine months of 2017 decreased compared to the same period last year primarily due to margin decline in the Industrial and Healthcare Materials reportable segment driven by the impact of acquisitions and a program loss in personal care tapes.

#### Marketing, General and Administrative Expense

Marketing, general and administrative expense increased in the first nine months of 2017 compared to the same period last year reflecting the impact of acquisitions and higher employee-related costs, partially offset by benefits from productivity initiatives, including savings from restructuring, net of transition costs.

#### Other Expense, net

*(In millions)*

| Other expense, net by type Restructuring charges: | Nine Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Severance and related costs | $21.7 | $10.7 |
| Asset impairment charges and lease cancellation costs | 2.1 | 3.9 |
| Other items: |  |  |
| Transaction costs | 3.7 | 4.1 |
| Loss from settlement of pension obligations | – | 41.4 |
| Loss on sale of asset | – | .3 |
| Other expense, net | $27.5 | $60.4 |

Refer to Note 9, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding costs associated with restructuring.

Refer to Note 6, “Pension and Other Postretirement Benefits,” to the unaudited Condensed Consolidated Financial Statements for more information regarding loss from settlement of pension obligations.

### Net Income and Earnings per Share

*(Dollars in millions, except per share amounts)*

|  | Nine Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Income before taxes | $432.2 | $350.8 |
| Provision for income taxes | 90.8 | 92.1 |
| Net income | $341.4 | $258.7 |
| Net income per common share | $3.86 | $2.90 |
| Net income per common share, assuming dilution | 3.79 | 2.85 |
| Effective tax rate | 21.0% | 26.3% |

#### Provision for Income Taxes

The effective tax rate for the nine months ended September 30, 2017 included $3.2 million of tax benefit from the releases of valuation allowances on certain U.S. state deferred tax assets; $4.5 million of tax benefit from the effective settlements of certain tax examinations and changes in our judgment about tax filing positions as a result of new information; and $4.6 million of tax benefit from decreases in certain tax reserves, including interest and penalties, as a result of closing tax years.

The effective tax rate for the nine months ended September 30, 2017 also included a net benefit of $13.6 million related to our adoption of the accounting guidance update related to stock-based payments described in Note 1, “General,” to the unaudited Condensed Consolidated Financial Statements. The accounting guidance update related to stock-based payments requires that the effect of excess tax benefits associated with stock-based payments be recognized in the income statement instead of in capital in excess of par value as was the case prior to our adoption of this update. Excess tax benefits are the effects of tax deductions in excess of compensation expenses recognized for financial accounting purposes. These benefits related to stock-based awards are generally generated as a result of stock price appreciation during the vesting period or between the time of grant and the time of exercise. We expect future excess tax benefits pursuant to this update to vary depending on our stock-based payments in future reporting periods. These excess tax benefits may cause variability in our future effective tax rate as they can fluctuate based on vesting and exercise activity, as well as our future stock price. The tax effect of the tax deductions in excess of compensation cost related to the exercise of nonqualified stock options and vesting of other stock-based compensation awards recognized in capital in excess of par value was $10.0 million for the nine months ended October 1, 2016.

The effective tax rate for the nine months ended September 30, 2017 also included the immediate recognition of $1.6 million of tax expense primarily from intra-entity sales and transfers of assets other than inventory related to the integration of a recent acquisition. The remaining tax effects were recognized as deferred tax charges and recorded in “Other current assets” and “Other assets.” However, we expect the deferred tax charges to be derecognized as an adjustment to retained earnings upon adoption of the accounting guidance update described in Note 17, “Recent Accounting Requirements,” to the unaudited Condensed Consolidated Financial Statements.

In addition, the effective tax rate for the nine months ended September 30, 2017 compared to the same period last year reflects a decrease in tax expense related to the repatriation of non-permanently reinvested earnings of certain foreign subsidiaries and favorable changes in the geographic mix of our income before taxes.

The effective tax rate for the nine months ended October 1, 2016 included $3.1 million of tax expense resulting from return to provision adjustments pursuant to the completion of the 2015 U.S. federal tax return; $7.1 million of tax benefit from our change in judgment about tax filing positions in certain foreign jurisdictions as a result of new information gained from our interactions with tax authorities; $26.9 million of tax expense associated with the tax cost to repatriate non-permanently reinvested earnings of certain foreign subsidiaries; $11.1 million of tax benefit resulting from effective settlements of tax examinations in various foreign jurisdictions; $6.7 million of tax benefit from the releases of valuation allowances against certain deferred tax assets in a foreign jurisdiction associated with a structural simplification approved by the tax authority; and $3.3 million of tax benefit due to decreases in certain tax reserves as a result of closing tax years.

Our effective tax rate can vary widely from quarter to quarter due to interim reporting requirements, the recognition of discrete events and the timing of repatriation of foreign earnings. Refer to Note 11, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for further information.

### RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE NINE MONTHS YEAR-TO-DATE

Operating income refers to income before interest and taxes.

### Label and Graphic Materials

*(In millions)*

|  | Nine Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $3,397.9 | $3,172.8 |
| Less intersegment sales | (47.9) | (49.3) |
| Net sales | $3,350.0 | $3,123.5 |
| Operating income(1) | 429.3 | 395.6 |
| (1)Included costs associated with restructuring and transaction costs in both years. | $10.4 | $11.0 |

#### Net Sales

The factors impacting reported sales change are shown in the table below:

|  | Nine Months Ended September 30, 2017 |
| --- | ---: |
| Reported sales change | 7% |
| Foreign currency translation | – |
| Sales change ex. currency | 7% |
| Acquisitions | (3) |
| Organic sales change | 4% |

In the first nine months of 2017, net sales increased on an organic basis primarily due to higher volume. Net sales increased on an organic basis at a high-single digit rate in emerging markets, a mid-single digit rate in Western Europe, and a low-single digit rate in North America.

#### Operating Income

Operating income increased in the first nine months of 2017 compared to the same period last year primarily reflecting higher volume/mix and benefits from productivity initiatives, including savings from restructuring, net of transition costs, partially offset by higher employee-related costs and the net impact of pricing and raw material costs.

### Retail Branding and Information Solutions

*(In millions)*

|  | Nine Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $1,118.0 | $1,071.8 |
| Less intersegment sales | (2.3) | (2.3) |
| Net sales | $1,115.7 | $1,069.5 |
| Operating income(1) | 80.1 | 67.8 |
| (1) Included costs associated with restructuring and transaction costs in both years, and loss on sale of an asset in 2016. | $14.0 | $7.1 |

#### Net Sales

The factors impacting reported sales change are shown in the table below:

|  | Nine Months Ended September 30, 2017 |
| --- | ---: |
| Reported sales change | 4% |
| Foreign currency translation | 1 |
| Sales change ex. currency | 5% |
| Organic sales change | 5% |

In the first nine months of 2017, net sales increased on an organic basis due to higher volume reflecting growth in both radio-frequency identification products and base apparel tickets and tags.

#### Operating Income

Operating income increased in the first nine months of 2017 compared to the same period last year reflecting higher volume and benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, partially offset by higher employee-related costs and higher restructuring charges.

### Industrial and Healthcare Materials

*(In millions)*

|  | Nine Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $418.1 | $348.7 |
| Less intersegment sales | (5.3) | (6.0) |
| Net sales | $412.8 | $342.7 |
| Operating income(1) | 37.6 | 44.8 |
| (1) Included costs associated with restructuring in both years and transaction costs in 2017. | $3.1 | $.9 |

#### Net Sales

The factors impacting reported sales change are shown in the table below:

|  | Nine Months Ended September 30, 2017 |
| --- | ---: |
| Reported sales change | 20% |
| Foreign currency translation | 1 |
| Sales change ex. currency | 21% |
| Acquisitions | (20) |
| Organic sales change | 1% |

In the first nine months of 2017, net sales increased slightly on an organic basis primarily due to higher volume, as growth in industrial categories largely offset the anticipated decline in healthcare categories.

#### Operating Income

Operating income decreased in the first nine months of 2017 compared to the same period last year due to higher employee-related costs, including growth investments, as well as the net impact of pricing and raw material costs, partially offset by benefits from productivity initiatives, including savings from restructuring actions, net of transition costs. The net impact of acquisitions was not material.

### FINANCIAL CONDITION

### Liquidity

### Operating Activities

*(In millions)*

|  | Nine Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Net income | $341.4 | $258.7 |
| Depreciation and amortization | 134.8 | 135.5 |
| Provision for doubtful accounts and sales returns | 28.1 | 33.8 |
| Net losses from asset impairments and sales/disposals of assets | 2.4 | 3.8 |
| Stock-based compensation | 22.2 | 20.1 |
| Loss from settlement of pension obligations | – | 41.4 |
| Other non-cash expense and loss | 41.0 | 34.7 |
| Changes in assets and liabilities and other adjustments | (177.3) | (162.3) |
| Net cash provided by operating activities | $392.6 | $365.7 |

For cash flow purposes, changes in assets and liabilities and other adjustments exclude the impact of foreign currency translation (discussed below in “Analysis of Selected Balance Sheet Accounts”).

During the first nine months of 2017, cash flow from operating activities increased compared to the same period last year primarily due to higher net income, partially offset by higher income tax payments, net of refunds, and operational working capital improvements in the prior year, the benefit of which did not repeat in the current year. In addition, in the first nine months of 2017, operating activities reflected the impact of our adoption of the accounting guidance update related to stock-based payments described in Note 1, “General,” to the unaudited Condensed Consolidated Financial Statements.

### Investing Activities

*(In millions)*

|  | Nine Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Purchases of property, plant and equipment | $(111.4) | $(104.9) |
| Purchases of software and other deferred charges | (23.5) | (16.6) |
| Proceeds from sales of property, plant and equipment | 3.0 | 4.3 |
| Purchases of investments, net | (4.7) | (.8) |
| Payments for acquisitions, net of cash acquired, and investments in businesses | (309.5) | (227.5) |
| Net cash used in investing activities | $(446.1) | $(345.5) |

#### Capital and Software Spending

During the first nine months of 2017, we invested in new equipment to support growth in Asia, Europe, and North America, and to improve manufacturing productivity. During the first nine months of 2016, we invested in new equipment to support growth, primarily in Asia, and to improve manufacturing productivity.

During the first nine months of 2017 and 2016, we invested in information technology primarily associated with enterprise resource planning system implementations in North America, Asia, and Europe.

#### Payments for Acquisitions and Investments in Businesses

During the first nine months of 2017 and 2016, the aggregate payments for acquisitions, net of cash acquired, and investments in businesses were approximately $310 million and $228 million, respectively, which we funded through cash and commercial paper borrowings.

Refer to Note 2, “Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Financing Activities

*(In millions)*

|  | Nine Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| Net (decrease) increase in borrowings (maturities of three months or less) | $(220.1) | $242.0 |
| Additional long-term borrowings | 526.6 | – |
| Repayments of long-term debt | (2.5) | (1.9) |
| Dividends paid | (115.8) | (106.2) |
| Share repurchases | (104.8) | (181.5) |
| Proceeds from exercises of stock options, net | 17.7 | 63.4 |
| Tax withholding for and excess tax benefit from stock-based compensation, net | (20.3) | (4.4) |
| Net cash provided by financing activities | $80.8 | $11.4 |

#### Borrowings and Repayment of Debt

Given the seasonality of our cash flow from operating activities, during the first nine months of 2017 and 2016, our commercial paper borrowings were used to fund share repurchase activity, dividend payments, and capital expenditures. During the first nine months of 2017 and 2016, commercial paper borrowings were also used to fund acquisitions.

In March 2017, we issued €500 million of senior notes, due March 2025. The senior notes bear an interest rate of 1.25% per year, payable annually in arrears. The net proceeds from the offering, after deducting underwriting discounts and estimated offering expenses, were $526.6 million (€495.5 million), a portion of which was used to repay commercial paper borrowings that we used to finance a portion of our acquisition of Mactac in August 2016 and the remainder of which was used for general corporate purposes, including acquisitions.

Refer to Note 2, “Acquisitions,” and Note 5, “Debt,” to the unaudited Condensed Consolidated Financial Statements for more information.

#### Dividend Payments

We paid dividends of $1.31 per share in the first nine months of 2017 compared to $1.19 per share in the same period last year. In April 2017, we increased our quarterly dividend to $.45 per share, representing an increase of approximately 10% from our previous dividend rate of $.41 per share.

#### Share Repurchases

During the first nine months of 2017, we repurchased 1.3 million shares of our common stock at an aggregate cost of $104.8 million. During the first nine months of 2016, we repurchased 2.7 million shares of our common stock at an aggregate cost of $181.5 million.

In April 2017, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $650 million, exclusive of any fees, commissions or other expenses related to such purchases and in addition to any amount outstanding under our previous Board authorization. Our Board repurchase authorizations remain in effect until shares in the respective amount authorized thereunder have been repurchased.

As of September 30, 2017, shares of our common stock in the aggregate amount of $650.1 million remained authorized for repurchase under our outstanding Board authorizations.

#### Tax Withholding for and Excess Tax Benefit from Stock-Based Compensation, Net

During the first nine months of 2017, tax withholding for and excess tax benefit from stock-based compensation, net, reflected the impact of our adoption of the accounting guidance update related to stock-based payments described in Note 1, “General,” to the unaudited Condensed Consolidated Financial Statements.

### Analysis of Selected Balance Sheet Accounts

#### Long-lived Assets

In the nine months ended September 30, 2017, property, plant and equipment, net, increased by approximately $132 million to $1.05 billion, which primarily reflected the preliminary valuation of property, plant and equipment from the 2017 Acquisitions of approximately $68 million, as well as purchases of property, plant and equipment, partially offset by depreciation expense.

In the nine months ended September 30, 2017, goodwill increased by approximately $184 million to $977.1 million, which reflected the preliminary valuation of goodwill associated with the 2017 Acquisitions, the impact of foreign currency translation, and purchase price allocation adjustments associated with our acquisition of Mactac in August 2016.

In the nine months ended September 30, 2017, other intangibles resulting from business acquisitions, net, increased by approximately $103 million to $170.1 million, which reflected the preliminary valuation of other intangibles from the 2017 Acquisitions and the impact of foreign currency translation, partially offset by current year amortization expense.

Refer to Note 2, “Acquisitions,” and Note 4, “Goodwill and Other Intangibles Resulting from Business Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.

In the nine months ended September 30, 2017, other assets increased by approximately $42 million to $445.1 million, which reflected an increase to deferred tax charges associated with the integration of a recent acquisition, an increase in the cash surrender value of our corporate-owned life insurance policies, and the impact of foreign currency translation, partially offset by amortization expense related to software and other deferred charges, net of purchases.

Refer to Note 11, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for more information.

#### Shareholders’ Equity Accounts

In the nine months ended September 30, 2017, the balance of our shareholders’ equity increased by approximately $209 million to $1.13 billion, which primarily reflected net income, the use of treasury shares to settle stock-based awards and fund contributions to our U.S. defined contribution plan, and the impact of foreign currency translation. These increases were partially offset by dividend payments and share repurchases.

### Impact of Foreign Currency Translation

*(In millions)*

|  | Nine Months Ended September 30, 2017 |
| --- | ---: |
| Change in net sales | $(13) |
| Change in net income | (3) |

International operations generated approximately 76% of our net sales during the nine months ended September 30, 2017. Our future results are subject to changes in political and economic conditions in the regions in which we operate and the impact of fluctuations in foreign currency exchange and interest rates.

The unfavorable impact of foreign currency translation on net sales in the first nine months of 2017 compared to the same period last year was primarily related to sales in China and Turkey, and euro-denominated sales, partially offset by sales in Brazil.

### Effect of Foreign Currency Transactions

The impact on net income from transactions denominated in foreign currencies is largely mitigated because the costs of our products are generally denominated in the currencies in which they are sold. In addition, to reduce our income and cash flow exposure to transactions in foreign currencies, we enter into foreign exchange forward, option and swap contracts where available and appropriate. We also utilize certain foreign currency denominated debt to mitigate foreign currency exposure related to our investment in foreign operations.

### Analysis of Selected Financial Ratios

We utilize the financial ratios discussed below to assess our financial condition and operating performance.

#### Working Capital (Deficit) and Operational Working Capital Ratios

The increase in working capital (deficit) (current assets minus current liabilities), as a percentage of annualized net sales, of 4% in the first nine months of 2017 compared to (.7)% in the first nine months of 2016 was primarily the result of a decrease in short-term borrowings and current portion of long-term debt and capital leases, as well as increases in trade accounts receivable, net. The decrease in short-term borrowings and current portion of long-term debt and capital leases was a result of the repayment of commercial paper borrowings used to finance a portion of our acquisition of Mactac in August 2016 using senior notes issued in March 2017. Refer to “Borrowings and Repayment of Debt” for more information.

The increase in operational working capital, as a percentage of annualized net sales, reconciled with working capital below, of 13.2% in the first nine months of 2017 compared to 12.7% in the first nine months of 2016 was primarily the result of the impact of acquisitions. Our objective is to minimize our investment in operational working capital, as a percentage of annualized net sales, to maximize cash flow and return on investment.

*(Dollars in millions)*

|  | Nine Months Ended September 30, 2017 | October 1, 2016 |
| --- | ---: | ---: |
| (A) Working capital (deficit) | $260.0 | $(42.5) |
| Reconciling items: |  |  |
| Cash and cash equivalents | (232.3) | (189.4) |
| Assets held for sale | (6.8) | (5.9) |
| Other current assets | (239.4) | (183.3) |
| Short-term borrowings and current portion of long-term debt and capital leases | 383.0 | 587.6 |
| Accrued payroll and employee benefits and other current liabilities | 691.1 | 601.8 |
| (B) Operational working capital | $855.6 | $768.3 |
| (C) Annualized net sales (year-to-date sales, divided by three and multiplied by four) | $6,504.7 | $6,047.6 |
| Working capital (deficit), as a percentage of annualized net sales (A) ÷ (C) | 4.0% | (.7)% |
| Operational working capital, as a percentage of annualized net sales (B) ÷ (C) | 13.2% | 12.7% |

#### Accounts Receivable Ratio

The average number of days sales outstanding, calculated using the three-quarter average trade accounts receivable balance divided by the average daily sales for the first nine months, was 64 days in the first nine months of 2017 and 63 days in the first nine months of 2016. The increase in the average number of days sales outstanding from the prior year primarily reflected the impact of acquisitions and the timing of collections.

#### Inventory Ratio

Average inventory turnover, calculated using the annualized cost of sales (cost of sales for the first nine months, divided by three and multiplied by four) divided by the three-quarter average inventory balance, was 7.8 in the first nine months of 2017 and 8.5 in the first nine months of 2016. The decrease in the current year average inventory turnover primarily reflected the impact of acquisitions and the timing of inventory purchases.

#### Accounts Payable Ratio

The average number of days payable outstanding, calculated using the three-quarter average accounts payable balance divided by the average daily cost of products sold for the first nine months, was 72 days in both the first nine months of 2017 and 2016.

### Capital Resources

Capital resources include cash flows from operations, cash and cash equivalents and debt financing. At September 30, 2017, we had cash and cash equivalents of approximately $232 million held in accounts at third-party financial institutions.

Our cash balances are held in numerous locations throughout the world. At September 30, 2017, the majority of our cash and cash equivalents was held by our foreign subsidiaries.

To meet U.S. cash requirements, we have several cost-effective liquidity options available. These options include borrowing funds at reasonable rates, including commercial paper, borrowings from foreign subsidiaries, and repatriating foreign earnings. However, if we were to repatriate incremental foreign earnings, we may be subject to additional taxes in the U.S.

Our $700 million revolving credit facility (the “Revolver”) contains financial covenants requiring that we maintain specified ratios of total debt and interest expense in relation to certain measures of income. As of September 30, 2017 and December 31, 2016, we were in compliance with our financial covenants.

In March 2017, we issued €500 million of senior notes, due March 2025. The senior notes bear an interest rate of 1.25% per year, payable annually in arrears. Refer to Note 5, “Debt,” to the unaudited Condensed Consolidated Financial Statements for more information.

On October 2, 2017, subsequent to the end of the third quarter of 2017, we repaid $250 million of senior notes at maturity using commercial paper borrowings.

We are currently in the process of amending the Revolver to, among other things, increase our borrowing capacity under our current agreement.

We are exposed to financial market risk resulting from changes in interest and foreign currency rates, and to possible liquidity and credit risks of our counterparties.

#### Capital from Debt

Our total debt increased by approximately $389 million in the first nine months of 2017 to $1.68 billion, primarily reflecting the issuance of senior notes in March 2017. Refer to “Financing Activities” above for more information.

Credit ratings are a significant factor in our ability to raise short- and long-term financing. The credit ratings assigned to us also impact the interest rates paid and our access to commercial paper, credit facilities, and other borrowings. A downgrade of our short-term credit ratings could impact our ability to access the commercial paper markets. If our access to commercial paper markets were to become limited, the Revolver and our other credit facilities would be available to meet our short-term funding requirements, if necessary. When determining a credit rating, we believe that rating agencies primarily consider our competitive position, business outlook, consistency of cash flows, debt level and liquidity, geographic dispersion and management team. We remain committed to maintaining an investment grade rating.

### Off-Balance Sheet Arrangements, Contractual Obligations, and Other Matters

Refer to Note 15, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements.

### RECENT ACCOUNTING REQUIREMENTS

Refer to Note 17, “Recent Accounting Requirements,” to the unaudited Condensed Consolidated Financial Statements.

## Market risk

As filed, 162 characters.

There have been no material changes to the information provided in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

## Controls and procedures

As filed, 3,073 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(f)) that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our disclosure controls system is based upon a global chain of financial and general business reporting lines that converge in our headquarters in Glendale, California. As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such time to provide reasonable assurance that information was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

### Changes in Internal Control Over Financial Reporting

We periodically assess our internal control environment. During 2014, we began a phased implementation of a new transactional system in our Retail Branding and Information Solutions reportable segment that is expected to continue through 2021. Processes affected by this implementation include order management, pricing, shipping, general accounting, manufacturing and planning. Where appropriate, we are reviewing related internal controls and making changes. Other than this implementation, there have been no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We are currently in the process of reviewing our internal control structure related to the 2017 Acquisitions. We will make any necessary changes as we integrate the 2017 Acquisitions into our overall process of internal control over financial reporting.

## Risk factors

As filed, 163 characters.

There have been no material changes to the risk factors included in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Filed Oct 31, 2017.
Source: SEC EDGAR, the filing index for accession 0001104659-17-064943. Last ingested by Listed: Nov 10, 2026, 16:39 ET. No prices; not investment advice.
